Literature DB >> 3263995

Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability.

H Kiat1, D S Berman, J Maddahi, L De Yang, K Van Train, A Rozanski, J Friedman.   

Abstract

Twenty-one patients were studied who underwent thallium-201 stress-redistribution single photon emission computed tomography (SPECT) both before and after coronary artery bypass grafting (n = 15) or transluminal coronary angioplasty (n = 6). All patients underwent thallium imaging 15 min, 4 h and late (18 to 72 h) after stress as part of the preintervention thallium-201 scintigram. In a total of 201 tomographic myocardial segments with definite post-stress thallium-201 perfusion defects in which the relevant coronary arteries were subsequently successfully reperfused, the 4 h redistribution images did not predict the postintervention scintigraphic improvement: 67 (85%) of the 79 4 h reversible as well as 88 (72%) of the 122 4 h nonreversible segments improved (p = NS). The 18 to 72 h late redistribution images effectively subcategorized the 4 h nonreversible segments with respect to postintervention scintigraphic improvement: 70 (95%) of the 74 late reversible segments improved after intervention, whereas only 18 (37%) of the 48 late nonreversible segments improved (p less than 0.0001). The frequency of late reversible defects and the frequency of postrevascularization improvement of late nonreversible defects are probably overestimated by this study because of referral biases. The cardiac counts and target to background ratios from late redistribution studies resulted in satisfactory cardiac images for visual interpretation. For optimal assessment of the extent of viable myocardium by thallium-201 scintigraphic studies, late redistribution imaging should be performed when nonreversible defects are observed on 4 h redistribution images.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263995     DOI: 10.1016/s0735-1097(88)80009-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  64 in total

1.  Use of myocardial perfusion imaging to assess viability.

Authors:  M I Travin
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

Review 2.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

3.  Exercise four hour redistribution thallium-201 single photon emission computed tomography and exercise induced ST segment elevation in detecting the viable myocardium in patients with acute myocardial infarction.

Authors:  H Yamagishi; K Akioka; M Takagi; A Tanaka; K Takeuchi; J Yoshikawa; H Ochi
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

4.  The clinical impact of thallium-201 reinjection scintigraphy for detection of myocardial viability.

Authors:  A F Kuijper; H W Vliegen; E E van der Wall; W P Oosterhuis; A H Zwinderman; B L van Eck-Smit; M G Niemeyer; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1992

5.  Viable myocardium and reinjection of thallium.

Authors:  S R Underwood; D J Pennell
Journal:  Br Heart J       Date:  1992-12

Review 6.  The historical and conceptual evolution of radionuclide assessment of myocardial viability.

Authors:  James E Udelson; Robert O Bonow; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

Review 7.  Hibernation and myocardial ischemia: clinical detection by positron emission tomography.

Authors:  N G Uren; P G Camici
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

8.  Myocardial perfusion and function single photon emission computed tomography.

Authors:  Christopher L Hansen; Richard A Goldstein; Daniel S Berman; Keith B Churchwell; C David Cooke; James R Corbett; S James Cullom; Seth T Dahlberg; James R Galt; Ravi K Garg; Gary V Heller; Mark C Hyun; Lynne L Johnson; April Mann; Benjamin D McCallister; Raymond Taillefer; R Parker Ward; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

9.  Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy.

Authors:  A Cuocolo; S Maurea; L Pace; E Nicolai; A Nappi; M Imbriaco; B Trimarco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-12

10.  The value of Tc-99m MIBI SPECT during isosorbide dinitrate infusion in assessment of viable myocardium in patients with myocardial infarction.

Authors:  S T Li; X J Liu; Z L Lu; X D Zhu; R F Shi; Y J Yang; F Lu; W Q Chen; Q W Wu; Y Z Lu
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.